What To Expect During OIG Site Visits

When operating under a Corporate Integrity Agreement or an Integrity Agreement, an HHS OIG site visit is a possibility. The OIG’s website outlines the basics like who conducts site visits, how long they typically last, and what topics tend to come up.  But leaders often want more clarity once notice arrives. Join Catapult Healthcare Consulting, LLC on October 7, 2026, at 2:00 pm (ET) for a webinar that goes beyond the OIG’s FAQs. Led by our Principal Consultant, a former HHS OIG Senior Attorney who conducted site visits during her tenure, the session covers what typically happens on site and where preparation time tends to be well spent. 

You’ll learn:

·         What can get the OIG’s attention during the facility tour

·         Why certain employees may be selected for interviews

·         How to handle something unexpected that surfaces mid-visit

Register to reserve your spot. Registration closes on October 2, 2026.

Presenter

S. Jnatel Sims, J.D. is the Principal Consultant of Catapult Healthcare Consulting, LLC.  She is a licensed attorney and compliance professional with more than 26 years of experience in business, legal, and government settings. Ms. Sims offers a distinctive perspective shaped by her experience on both sides of healthcare regulation as a government regulator and as a compliance leader within regulated entities. Before founding Catapult Healthcare Consulting, LLC, Ms. Sims served as a Senior Attorney in the Office of Inspector General for the U.S. Department of Health and Human Services. There, she negotiated and monitored Corporate Integrity Agreements, conducted OIG site visits, evaluated compliance programs, and handled cases involving federal healthcare fraud, waste and abuse authorities.  For her role in significant healthcare fraud matters, she earned the Inspector General’s Exceptional Achievement Award​​. Ms. Sims also has held executive-level roles within managed care companies and healthcare systems, where she developed and oversaw comprehensive compliance programs and provided strategic guidance to leadership and Boards on regulatory compliance and program performance.